sustained clinical benefits across different adult patient populations living with this common inflammatory skin condition.1-4 "A primary treatment goal for people living with psoriasis is durable, high rates of complete skin clearance. These...
MedaSystems, the leading SaaS platform for Expanded Access (EA) and Investigator-Initiated Studies (IIS), announced additional funding from existing investors, Debiopharm Innovation Fund, Nina Capital, and Young Sohn, a co-founder of Veeva...
In a significant development for the clinical diagnostics landscape in Singapore, Angsana Molecular & Diagnostics Laboratory (Angsana) and Pathnova Laboratories (Pathnova) have announced their merger to form Archerfish Precision Diagnostics...
to provide necessary treatment options to patients with cancer.” In 2024, an estimated 9,280 people were diagnosed with CML1, over 10,000 with MDS/MPD2, and up to 6,000 with GIST3 in the U.S. Despite the proven clinical benefits of imatinib,...
("Latigo") announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation (FTD) to LTG-001, the company's oral, investigational selective Nav1.8 inhibitor for the treatment of acute pain. LTG-001 works by blocking...
lasting 30–60 minutes, depending on the size of the nodule. Patients remain under observation for an additional 60–120 minutes before discharge. Dr. Grady uses STARmed's industry-leading RF technology to ensure the highest standard of care with the...
TOOsonix A/S, a leader in high-intensity focused ultrasound technology for dermatology, has partnered with MikronMed AB, a top distributor of medical equipment in the Nordic region. The collaboration will bring TOOsonix innovative MDR CE marked...
Neurosurgeon Jeffrey Schweitzer, M.D., Ph.D., the George A. Lopez, MD Endowed Chair in Neurosurgery, is leading a Phase 1 trial at Mass General Brigham. “Using a patient’s own cells as a starting point has clear advantages such as minimizing...
biotherapeutics, announced the appointment of Ashley Scholz as Vice President of Marketing. Ashley brings over 16 years of experience in marketing leadership within the medical device, cancer diagnostics, and molecular diagnostics industries. In...
the leading clinical trials laboratories in Australia, managing large biotech and pharmaceutical clinical trials from Phase 1 to Phase 4 studies. With a vast network of laboratories across Australia, ACL Specialised Trials has extensive experience...
with Regemat 3D's mission to provide state-of-the-art bioprinting solutions. Regemat 3D has grown to become one of the top 15 3D bioprinting emerging companies worldwide, with a presence in more than 30 countries and collaborators in over 100...
studies in which humanized sickle cell mice topically treated with Vascarta's transdermal curcumin gel formulation ("VAS-101") experienced reduced pain and inflammation along with improved red blood cell stability and functionality. Based in part...
skin. Revolutionizing Collagen Filler Technology SKINCOLLA is a game-changer in aesthetic treatments. It combines 100% human-identical recombinant collagen with Hyaluronic Acid (HA), providing immediate and lasting improvements to skin texture,...
PharmAID Decision Intelligence Platform Integrates Global Leading Large Model Technology and Has connected with Deepseek R1 As a pioneer in the AI transformation of the pharmaceutical industry, Fosun Pharma recently launched its self-developed...
strategic approach and its ability to adapt and succeed in dynamic market conditions. With a vision to rank among the top 100 pharmaceutical companies globally, Grindeks continues to drive innovation, expand its reach, and strengthen its...
Verma, president of Fresenius Kabi Region U.S. and member of the executive leadership team at Fresenius Kabi AG. Since 2017, Fresenius Kabi has invested nearly $1 billion to modernize and expand its advanced U.S. pharmaceutical production and...
The safety and efficacy of KYZATREX was demonstrated in a phase 3, multi-center, open-label, six-month study in 155 hypogonadal males between 18 and 65 years of age with documented hypogonadism, as defined by a below normal serum testosterone level...
clinically-proven total disc replacement (TDR) technology platform in the world (prodisc®), announced the completion of the 10,000th case in the U.S. with the Match-the-Disc™ prodisc Cervical TDR System. The new Match-the-Disc prodisc Cervical TDR...
Global Business Units, Healthcare, at Jabil. Jabil is a leader in parenteral drug delivery, in support of markets like GLP-1s. This acquisition will significantly enhance Jabil’s existing Pharmaceutical Solutions offering, which includes the...
transforming drug discovery, welcomes imec.xpand to its Series A syndicate, bringing the total capital raised to USD 31 million. imec.xpand is joined by existing investors Prime Movers Lab, Kofa Healthcare, and Global Brain in this financing....